🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!
1. MF59-aQIV looks economically persuasive in Korea and Taiwan — but the price assumptions do a lot of the work This modelling study assessed the cost-effectiveness of MF59-adjuvanted quadrivalent influenza vaccine...
World Immunization Week (24–30 April) has become the flagship moment each year when the global immunization community pauses, takes stock, and speaks with one voice about the power of vaccines. Each April, the World...
Global vaccination policy this week feels less like harmonized orchestration and more like controlled fragmentation—with a purpose. European and Western Pacific advisory groups are quietly locking in 2026–2027...
Copyright © 2009-2026 Global Health Press Pte Ltd. Reg. No. 200921795N All Rights Reserved.
Subject to Creative Commons Licence (cc).